Clinical Alert: New Treatment Significantly Improves Long-term Outlook For Breast Cancer Survivors:
International clinical trial concludes women should consider taking letrozole after five years of tamoxifen treatment to continue to reduce risk of recurrence

Last updated: 14 October 2003
First published: 09 October 2003
Metadata| Permanence level: Permanent: Unchanging Content